German researchers tie cold viruses used to deliver COVID-19 vaccine to rare blood clot risk

The researchers, in a study not yet reviewed by experts, said COVID-19 vaccines that employ adenovirus vectors - cold viruses used to deliver vaccine material - send some of their payload into the nucleus of cells, where some of the instructions for making coronavirus proteins can be misread.

from International-News-Economic Times https://ift.tt/3fqOcFa
via IFTTT

SHARE